Anna Jaques Hospital and Beth Israel Deaconess Medical Center have joined forces to bring comprehensive cancer care to the Newburyport area.
This new comprehensive cancer collaboration is an expansion of an already existing and successful relationship between AJH and BIDMC. Together, the two institutions offer a full array of community-based cancer services in Newburyport and when needed, advanced treatment options and specialists at BIDMC in Boston.
The program offers a committed team that works together to diagnose and direct the treatment of all types of cancers. Patients no longer have to travel to Boston to have world-class cancer specialists on their care team.
In recent years, advances in life-saving treatment options have brought new hope to cancer patients. Surgical techniques like minimally-invasive surgery and treatment options, including radiation, hormonal (anti-estrogen) therapy, chemotherapy, medical management and more, are now available. Deciding on one’s course of treatment and the options available is a collaborative approach between you and your family, your doctors, and caregivers.
“The team of cancer specialists at these two institutions is committed to providing to the Anna Jaques community leading-edge cancer care, encompassing a full spectrum of diagnostic and treatment programs. We are pleased to establish this affiliation that brings the best of Boston’s cancer care to Newburyport.” Dr. Kevin Tabb, President and CEO of BIDMC
The team of cancer specialists at Anna Jaques and Beth Israel Deaconess Medical Center is committed to providing to the Anna Jaques community leading-edge cancer care, encompassing a full spectrum of diagnostic and treatment programs. Patients are cared for through a collaboration of experts at both institutions with extensive experience in the diagnosis and treatment of cancer.
Our team of highly trained caregivers includes board certified, highly skilled medical oncologists, radiation oncologists, radiologists, surgeons, pathologists, nurses, therapists, pharmacists, technologists, support staff and other professionals dedicated to treating cancer patients. All our permanent nurses are certified in oncology, and nurses in our chemotherapy infusion room are also certified in oncology. Most of our volunteers are retired nurses, too.
The Tumor Board brings together a multidisciplinary group of physicians who review individual cancer cases in detail. This ensures that cancer patients have access to the best current thinking about cancer management and latest treatment options available. Oncology specialists from BIDMC join the Cancer Center's bi-weekly Tumor Board conferences via secure teleconferencing technology. They participate in the diagnosis and treatment planning of every patient.
Breast cancer patients participate in a multidisciplinary clinic in which the patient receives care from specialists from many disciplines in one convenient session, in one place.
Dr. Eneman is board certified in internal medicine, hematology and oncology, and will serve as the new medical director of the cancer center. Dr. Eneman received his medical degree from the University of Vermont (UVM), served as an intern and resident at Beth Israel Deaconess Medical Center (BIDMC), and completed his fellowship in Hematology and Medical Oncology at UVM. After completing his fellowship, Dr. Eneman accepted a position with York Hospital in York, Maine where he proudly served as Chairman for the Department of Medicine and helped the oncology program receive the New Program Outstanding Achievement Award from the American College of Surgeons Commission on Cancer. He is inspired daily by both his coworkers and patients.
Gabriele Southgate, MD, is a board-certified Internist and Hematology/Oncology specialist who brings more than 28 years of experience to the Cancer Center. She joins Medical Director Jonathan Eneman, MD, and Program Director Laura Rossi, RN, MS, OCN, to offer convenient, community-based cancer care. Her clinical interests include: breast cancer, chemotherapy for the elderly, lung cancer, lymphoma, thrombosis, and palliative supportive care. Dr. Southgate received her medical degree at University Medical Center Hamburg, Germany. She completed her residency in Internal Medicine at Metrowest Medical Center, Boston University and University of Massachusetts and her fellowship training at St. Elizabeth’s Medical Center, Tufts University School of Medicine. Dr. Southgate was also an Instructor of Medicine at Harvard Medical School for seven years and Assistant Professor of Medicine at UMass Memorial Medical Center.
Laura Rossi brings 23 years of experience to the role of Director of Oncology Services at AJH. After graduating from nursing school in 1986, she became board certified in Medical Surgery Nursing (RNC), board certified in Oncology Nursing (OCN) and certified in Biotherapy Chemotherapy (ONS). She also earned her Masters of Science in Nursing (MSN) and is certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS). Laura is an avid problem solver, a passionate patient advocate, and a true leader who empowers her staff to be the best they can be, all while infusing each and every day with laughter.
Nadine Tung, MD is the director of the Cancer Genetics and Prevention Program at the Cancer Center at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School.
In addition to her clinical work in cancer genetics, Dr. Tung is a breast cancer medical oncologist with expertise in caring for women with breast cancer. She is also active in research in the areas of breast cancer and hereditary susceptibility genes which cause breast and ovarian cancer.
Dr. Tung attended Harvard Medical School and completed her internship, residence and fellowship at Beth Israel Deaconess Medical Center in Boston. She is board certified by the American Board of Internal Medicine in Medical Oncology.
Dr. Fung is a board-certified radiation oncologist trained at Harvard Medical School and then Massachusetts General Hospital, where she earned a prestigious fellowship award and served on staff for 14 years. Dr. Fung has served as vice president of Commonwealth Hematology Oncology in Quincy, MA. She previously served as medical director at South Suburban Oncology Center in Quincy. Along with producing several original reports, reviews and abstracts, she has taught radiation oncology to medical students at Harvard Medical School and Boston University School of Medicine.
Stuart M. Berman, MD, MBA is director of community radiation oncology services for the Cancer Center at Beth Israel Deaconess Medical Center. He is an instructor in radiation oncology at Harvard Medical School. He attended the University of Virginia School of Medicine and completed his residency at the Harvard Joint Center for Radiation Therapy in 1992. He is board certified in radiation oncology by the American Board of Radiology.
Dr. Riley is a board-certified radiologist who earned his medical degree from Georgetown University School of Medicine and completed his post-graduate radiology training at Bridgeport Hospital in Bridgeport, Conn. Dr. Riley is a member of Northeast Radiology Associates, a partnership of radiologist that has provided diagnostic services to patients and referring physicians for more than 20 years.
Renowned for his role in leading-edge research, Marc B. Garnick MD serves as Director of Community Cancer Services for the Cancer Center at Beth Israel Deaconess Medical Center and is the Gorman Professor of Medicine at Harvard Medical School. Garnick received his bachelor degree from Bowdoin College and his medical degree from the University of Pennsylvania School of Medicine, where he also completed his internal medicine internship and residency. He also completed a research and clinical fellowship with the National Institutes of Health and a medical oncology fellowship at the Dana Farber Cancer Institute.
Garnick served as the principal investigator on the development of Lupron, a widely used hormonal therapy for prostate cancer and has also directed the clinical development of several other important cancer therapies. He currently serves on several advisory panels for the federal Food and Drug Administration, advising them on complicated issues related to the safety and efficacy of cancer treatments. He also serves as the editor in chief of the Harvard Medical School’s Annual Report on Prostate Diseases and its associated website, www.harvardprostateknowledge.org
Dr. Harris is a board-certified pathologist who works with the Aurora Diagnostics Seacoast Medical team based in Exeter, NH. A graduate of Harvard-Radcliffe College, she stayed in Boston to earn her medical degree at Boston University School of Medicine. Her post-graduate training includes a family practice residency at Boston Medical Center and a four-year pathology residency at Beth Israel Deaconess Medical Center, where she went on to complete a fellowship in surgical pathology in 2008, studying several types of cancer.
Dr. Peter Hartmann is a board-certified general surgeon who brings nearly 25 years of private surgical practice to the role of Medical Director. Since arriving in Newburyport, Dr. Hartmann has been involved with the American College of Surgeons’ Commission on Cancer since 1989. He has had a special interest in breast surgery for decades, and was among the first to use the sentinel node biopsy in New England in the 1990s. Over the years, he has performed approximately 1,000 breast procedures. As a dedicated breast surgeon he focuses exclusively on a variety of breast procedures related to the diagnosis and treatment of breast cancer.
Medical Oncology and Hematology refers to the treatment of cancer with medicines, as opposed to surgery or radiation. In some situations, these medicines are used in conjunction with surgery and radiation therapy. Medical Oncology and Hematology services provide chemotherapy treatment, immunotherapy, and treatment for blood disorders.
Traditional chemotherapy works by killing cells that divide rapidly. Cancer cells tend to multiply at a rapid rate. Therefore, the goal of chemotherapy is to destroy cancer cells.
The Oncology Infusion Suite has 12 semi-private treatment chairs. The oncology nursing staff delivers the latest cancer treatments to patients with the same intensity of care and the same chemotherapy and biotherapy drugs as those provided in leading Boston hospitals. The drugs are prepared on site by the Anna Jaques pharmacy staff. The team also administers supportive care medicines, pain management, blood transfusions and intravenous therapy.
The entire staff is specialty trained in oncology, and every nurse in the chemotherapy and infusion clinic is nationally certified in oncology nursing.
This type of treatment stimulates the body's own immune system to work more efficiently to fight the cancer.
Biologic therapy is often used to decrease the side effects of chemotherapy. It stimulates production of red blood cells to prevent anemia, and regulates production of white blood cells.
Treatment that adds, blocks or removes hormones can be used to treat certain cancers, such as breast and prostate cancer, that rely on hormones for tumor growth. To slow or stop the growth of these tumors, anti-hormone therapies may be given to block the body's natural hormone.
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") located on certain cancer cells. These therapies destroy the cancer cells while leaving normal healthy cells alone.
The radiation oncology suite houses the most advanced technology available for cancer care today, including a linear accelerator that offers Intensity Modulated Radiation Therapy (IMRT). Provided by Alliance Oncology, the IMRT delivers radiation therapy with great precision, destroying cancerous cells while preserving the healthy surrounding tissues. This advanced technology is operated by an experienced and highly accomplished staff of radiation therapy professionals. Patients in greater Newburyport and surrounding communities no longer have to drive long distances for their cancer care. They can find advanced technologies and a standard of care that rivals the most well respected cancer centers in the country.
Our Center offers two new cutting-edge medical systems designed to target and treat tumors with greater precision than ever before while preserving as much healthy tissue as possible. We offer the following advanced therapies combined with dedicated professionals who provide expert personalized care treating patients with respect and compassion every step of the way.
IMRT is a type of radiation treatment whereby the radiation beam is carefully sculpted around a patient's anatomy. Compared to conventional radiation therapy, IMRT provides more precise targeting of the tumor and greater sparing of surrounding normal organs. As a result, it allows safe increase in the radiation dose while minimizing side effects.
Physicians and physicists work together to create an IMRT plan. They create an extensive list of treatment objectives, and then work with a very advanced computer system to design hundreds of tiny radiation beams. Together these beams produce a high-precision radiation dose pattern in the patient. The treatment itself is carried out with the use of a "multi-leaf collimator" which has many small motorized rods of tungsten that do not allow radiation to penetrate through. These tungsten rods are programmed to move in and out of the radiation beam to deliver strategically shaped beams of radiation that conform to the tumor.
IMRT is particularly well suited for select patients with prostate cancer, head and neck cancer, and certain types of brain tumors, for example. Our physicians will guide you as to whether IMRT is the appropriate treatment for you.
IGRT is a technique used to track the internal movement of a patient's anatomy by imaging the patient each day during treatment and making fine positioning adjustments.
When a patient comes in for radiation treatment, the part of the body being treated is carefully positioned to the radiation beam. This is usually accomplished with lasers and markings on the outside of the body. In some instances, there can be a considerable amount of organ movement inside the patient's body and this can be corrected by the use of Image Guided Radiation Therapy.
In some cases, tiny radio-opaque markers are placed in the patient's body, and their location is used to align the patient for treatment. By following the daily movement of these markers and adjusting the radiation beam accordingly, treatment accuracy and precision are enhanced.
Before a patient's therapy can begin, a team of radiation physicists works with the physicians to develop a treatment plan. This plan is a complex set of instructions which is given to the linear accelerator (the radiation producing machine). It is designed to direct radiation to the cancerous cells while simultaneously protecting healthy tissues and organs.
The treatment plans are developed using a 3-dimensional conformal technique. Using a CT scan which allows 3-D visualization of the tumor and surrounding normal tissues, as well as a very sophisticated computer system, the physicians and physicists customize the shape of the radiation beams to the tumor's specific size and shape. This plan is then carried out with great precision each day of the patient's treatment.
Prostate cancer is the most common cancer among men. At Anna Jaques hospital, we’re committed to giving you the most effective therapy treatment. Prostate brachytherapy is the implanting of small radioactive “seeds” within the prostate, an alternative to surgically removing the prostate gland. With excellent success rates and limited side effects, this option is rapidly growing in popularity due to its effectiveness and convenience. Studies show that after brachytherapy, 87% of men with early stage diagnosis of the disease were cancer free 15 years after treatment.
The brachytherapy is performed by our team at Anna Jaques Hospital which is equipped with modern, 3D ultrasound technology. This provides the kind of visualization that allows radioactive seeds to be placed with extreme precision within the prostate gland. Best of all, this advanced treatment is located close to home, right at the Newburyport Medical Center.
Our committed team of experts from AJH and BIDMC work together to diagnose and direct the treatment of all types of cancers. Community-based cancer services are offered on the AJH campus and when needed, advanced treatment options and specialists at BIDMC in Boston.
Anna Jaques Cancer Center offers surgical treatment options and minimally invasive procedures for treating a variety of cancers. Our highly skilled surgical oncologists use new high definition (HD) cameras and minimally invasive surgery in the operating room to improve outcomes for patients. Minimally invasive surgery benefits patients by offering less scarring, less pain, a shorter hospital stay, less injury to tissue and a higher accuracy rate of eradicating the cancer. Our affiliation with BIDMC also means seamless access to more advanced surgical treatment in Boston, when appropriate.
The Cancer Genetics and Prevention Program at BIDMC provides genetic counseling and genetic testing to individuals at an increased risk for hereditary cancer syndromes. We work with Anna Jaques Cancer Center patients and their families to develop cancer screening and prevention strategies tailored to their individual cancer risks. Our services include:
If you are a new patient with our program click here.
Reconstruction of a breast that has been removed due to cancer or other disease is one of the most rewarding surgical procedures available today. New medical techniques and devices have made it possible for surgeons to create a breast that can come close in form and appearance to matching a natural breast. Frequently, reconstruction is possible immediately following breast removal (mastectomy), so the patient wakes up with a breast mound already in place, having been spared the experience of seeing herself with no breast at all.
Ask your surgeon about your options for breast reconstruction before surgery, so you can better prepare for a mastectomy with a more positive outlook for the future.
Anna Jaques Hospital welcomes individuals and families affected by cancer to join the new, free monthly support group. The group is open to anyone coping with a cancer diagnosis so that they can spend time with others facing similar situations. The group provides ongoing support, encouragement and friendship.
The group meets on the third Monday of every month from 5:30-7:30 at the Newburyport Medical Center (One Wallace Bashaw Way, Suite 2001, Newburyport). It is hosted by Susan M. Smith M.S.W., LICSW and the Chemotherapy Infusion Suite Nurses. Each month the support group features a different guest speaker to share helpful and educational information. Coffee and beverages will be served.
For more information, please call 978-463-1374.
Our two convenient, centrally located clinics in Newburyport are staffed with expert physical therapists, trainers and new equipment. Our licensed physical therapists are dedicated to excellence in the science and art of rehabilitation. They continually participate in advanced course work in their areas of specialization, so they can provide you with the most advanced and effective treatments available, including lymphedemia and aquatic therapy for cancer patients.
Our highly trained pet therapy dogs help heal the spirit while we help heal the body.
Local chapters of the American Cancer Society sponsor the programs listed below. To learn more call 1-800-ACS-2345, or visit www.cancer.org.
Created by, and for cancer survivors and their families to connect with others who have been touched by cancer. People in this virtual community share experiences, strength, and hope using the free, interactive service on the web through http://csn.cancer.org/.
A peer support program providing information and support by connecting women with someone who has been through the breast cancer experience herself--the Reach to Recovery volunteer. The patient may meet or talk to a volunteer at any point during her breast cancer experience.
A free magazine-catalog of products designed for women being treated for cancer to help ease the appearance-related side effects of cancer treatment. Product are available for breast cancer survivors, and women who have hair loss because of treatment.
A nationwide public service program helping women to overcome the appearance-related side effects associated with cancer treatment. Trained volunteers offer guidance and instruction to women in a supportive environment, helping them regain their confidence and self-esteem.
Our dedicated Patient Navigator, Kathy Porter, RN, OCN, at the Gerrish Breast Care Center is here for you, every step of the way. She will help you schedule the treatment you need, prepare you for your next appointment, and help educate and support the emotional needs of you and your family. Kathy has over 25 years of experience in nursing. She is an Oncology Certified Nurse (OCN) by the Oncology Nursing Society with additional training in breast health. She was a three year recipient of a Susan G. Komen for the Cure community grant and served as a community ambassador for the American Cancer Society. She has spoken at the local and national levels on patient navigation sharing her 14 years of experience in this specialized role.
A place for women who have received a diagnosis of breast cancer to be able to share their thoughts and feelings and support one another. 3rd Thursday of each month.
A free session based program designed specifically for those who have experienced breast cancer at any time in their lives. Incorporating gentile exercises, relaxation techniques, information and peer group support, is it safe, fun and therapeutic. Gentle but effective exercises improve strength, mobility and flexibility while the warm water relieves affected muscles. The exercise program is specifically designed to target areas that have been affected by breast cancer surgery and treatment.